Differences in GPIbα expression on platelets from ECMO compared to controls were less pronounced, but significance was achieved compared to CAD patients (MFI day 1 vs. CAD: 12,171 ± 641.8 vs. 15,349 ± 589.5, p = 0.03). This evidence concerns the gene GP1BA and coronary artery disorder.